Zhicheng Zhang
Harbin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
METTL7A Downregulation Drives SLC1A5-Mediated Glutamine Competition to Promote Tumor Proliferation and Suppress CD8+ T Cell Immunity in Gastric Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 31, 2026
NFYA transcriptionally activates GPX4 inhibiting ferroptosis in colorectal cancer.
Journal: Tissue & cell
Published: July 16, 2025
SLC7A11-AS1 contributes to prolonged activation of activin A/Smad signaling by suppressing PPM1A myristoylation in pancreatic cancer.
Journal: British journal of cancer
Published: March 21, 2025
The High-Quality Genome Sequencing and Analysis of Red Raspberry (Rubus idaeus L.).
Journal: International journal of genomics
Published: June 06, 2024
MCM8 promotes gastric cancer progression through RPS15A and predicts poor prognosis.
Journal: Cancer medicine
Published: November 24, 2023
KLF7 promotes colon adenocarcinoma progression through the PDGFB signaling pathway.
Journal: International journal of biological sciences
Published: May 21, 2023
Targeting the innate immune system with nanoparticles for cancer immunotherapy.
Journal: Journal of materials chemistry. B
Published: February 18, 2022
miR-33b-3p Acts as a Tumor Suppressor by Targeting DOCK4 in Prostate Cancer.
Journal: Frontiers in oncology
Published: July 13, 2021
Ellagic acid induces cell cycle arrest and apoptosis via the TGF‑β1/Smad3 signaling pathway in human colon cancer HCT‑116 cells.
Journal: Oncology reports
Published: August 15, 2019
Author Correction: Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells.
Journal: Cell death & disease
Published: August 14, 2019
Linc-DYNC2H1-4 promotes EMT and CSC phenotypes by acting as a sponge of miR-145 in pancreatic cancer cells.
Journal: Cell death & disease
Published: January 17, 2017
Showing 1-12 of 12
Last Updated: 09/26/2026